As a result of changes to the qualifying criteria for capital under the guidelines published by the Basel Committee on Banking Supervision (BCBS) on December 16, 2010 and January 13, 2011 and subsequent OSFI guidance regarding the treatment of non-qualifying capital instruments published on February 4, 2011, certain capital instruments may no longer qualify as capital beginning January 1, 2013. RBC’s non-common capital instruments will be considered non-qualifying capital instruments under Basel III and will therefore be subject to a 10 per cent phase-out per year beginning in 2013. These non-common capital instruments include preferred shares, trust capital securities and subordinated debentures.
The regulatory event redemption clause applies to RBC’s innovative tier 1 capital instruments (RBC trust capital securities). Based on current analysis, RBC does not intend to invoke the clause to effect early redemption of these instruments.
RBC maintains the right to redeem capital instruments based on other existing terms and conditions not linked to regulatory event clauses. RBC also retains the right to invoke any applicable regulatory event redemption clause in accordance with its terms should circumstances change.
Based on the rules as set out in OSFI’s February 4th Advisory regarding the Treatment of Non-Qualifying Capital Instruments, CIBC currently expects to exercise a regulatory event redemption only in 2022 and only in respect of the Series B Innovative Tier 1 Notes issued by CIBC Capital Trust.
Future circumstances within or outside CIBC’s control, including generally applicable legal changes that have the effect of causing non-qualifying regulatory capital to become compliant, may cause CIBC to change its expectation regarding the exercise of regulatory event redemptions and require CIBC to disclose an updated regulatory event redemption schedule.
As stated in the advisory, OSFI intends to adopt the Basel III changes in its domestic capital guidance. Under the Basel III rules text, any non-qualifying capital instruments outstanding as of 2022, the final year of the phase-out period, will not be recognized as regulatory capital. Based on the rules set out in OSFI’s advisory, TD currently expects to exercise a regulatory event redemption right only in 2022 in respect of the TD Capital Trust IVTM Notes – Series 2 outstanding at that time.
TD’s expectations are based on a number of factors and assumptions, including, but not limited to TD’s current and expected future capital position taking into account the expected redemptions of TD’s capital instruments, the assumption that other redemption rights, as applicable, are not exercised or other capital management actions are not taken, and current market conditions. These expectations are not intended to apply to capital instruments issued by TD’s U.S. subsidiaries. Given the uncertainty related to the financial, economic, legislative and regulatory environments, these factors – some of which are beyond TD’s control and the effects of which can be difficult to predict – could change materially over time and result in a change in the expectations expressed in this press release.
While the Bank has no present intention of invoking any regulatory event redemption features in its outstanding capital instruments, the Bank reserves the right to redeem, call or repurchase any capital instruments within the terms of each offering, in accordance with OSFI’s advisory.
BMO Financial Group today confirmed that it does not anticipate redeeming any of its outstanding regulatory capital instruments through the use of a regulatory capital event and that the Bank will not be disclosing a regulatory redemption event schedule. Regulatory capital instruments include the Bank’s outstanding preferred shares and subordinated debt, innovative tier 1 capital instruments issued by BMO Capital Trust and BMO Capital Trust II, and innovative tier 2 capital issued by BMO Subordinated Note Trust.
National Bank has not issued a press release at time of writing.
So those purchasing Innovative Tier 1 Capital securities at issue time, with the legitimate expectation that extant IT1C issues would be grandfathered in the event of rule changes (as was done with retractible preferred shares), and were willing to pay up for a long “no call” period … have had their expectations dashed.
And those who took the view that instruments would not be grandfathered, and took investment action on the basis of a legitimated expectation that the regulatory event clause would be applied in a manner consistent with the economic best interests of the issuer … have had their expectations dashed.
Those issuers with the foresight (and luck!) to issue Straight Preferred shares at the top of the market in the first quarter of 2007 and have been congratulating themselves ever since that they have financed with cheap money … have had their legitimate expectations dashed.
The OSFI advisory on extant issues was discussed in OSFI Does Not Grandfather Extant Tier 1 Capital. The probable new rules for Tier 1 are discussed at OSFI Releases Contingent Capital Draft Advisory. Rumours of potential bond index manipulation are discussed at OSFI Seeking to Manipulate Bond Indices and Retail Investors?.